New Medicines Discovery Institute Launched by Cardiff Uni

Cardiff University plans to launch the new Medicines Discovery Institute, increasing the development of new drugs for mental health such as anxiety and central nervous system conditions. The institute, which is part funded by the Welsh Government, the Higher Education Funding Council for Wales and the European Regional Development Fund, will develop novel medications to

Continue Reading

New nanoparticles wait to release drugs, target infection – Researchers from Washington State University

Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes. These microscopic particles are loaded with antibiotic and anti-inflammatory agents which are released when the particles encounter infection in the body. Researchers in the lab of Pharmaceutical Sciences Assistant Professor Zhenjia Wang

Continue Reading

World’s first “hands-free” drug discovery lab to be created in the UK

UK government has announced a new project to develop the world’s first fully-automated drug discovery facility with the aim to accelerate the production of new medicines and “transform” the pharma industry. Business Secretary, Greg Clark, stated that the venture, which is based at the government-funded research facility the Rosalind Franklin Institute in Harwell, Oxfordshire, will

Continue Reading

Government hopes new centre, Catapult, will put UK in the lead for cell and gene therapy

The forward-looking strategy by the government is set for success, providing it can translate its drug development and manufacturing lead into final local market access via the NHS. The strategy is aimed at learning lessons from previous decades, where the UK failed to convert ground-breaking scientific innovation into marketable products ahead of other nations. Keith

Continue Reading

Bicycle and CRUK to launch first clinical trial of bicyclic peptide for use in treating tumours

Bicycle Therapeutics and Cancer Research UK have commenced the first clinical study to assess a bicyclic peptide to evaluate its potential in patients with advanced solid tumours. The first patient has now been dosed in a Phase I/IIa trial with BT1718, a first-in-class Bicycle Toxin Conjugate that targets Membrane Type 1 Matrix Metalloproteinase, which is

Continue Reading

Novozymes sets up HelloScience, an online collaborative network for working on scientific solutions

Novozymes, a Danish biotech company, has set up an online network for individuals and companies to collaborate on solutions to major scientific problems called HelloScience. The network takes aim at five initial challenges, all based on a water theme, including developing an E. coli detection device. Approximately 18,000 children die each day from diarrhoea and

Continue Reading

Boehringer offers selected pre-clinical molecules to scientists worldwide for free via new platform

Boehringer Ingelheim has recently unveiled opnME.com, a centralised platform that allows access to selected pre-clinical molecules from its portfolio for free for non-clinical investigation by international scientists. The German pharmaceutical company hopes that the move will stimulate independent drug discovery and collaborative partnerships worldwide, in addition to the identification of novel treatment solutions for patients.

Continue Reading